Lonza supports development and manufacturing of ABL Bio’s bispecific antibody candidate with a complete and integrated end-to-end solution
EIP Pharma to initiate in 2Q 2023 a Phase 2b clinical study, funded in part by a $21 million grant from the National Institute of Aging
The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humans
Proposed combination enhances Pfizer’s position as a leading company in oncology
The collaboration will focus on developing a localized and sustained-release drug delivery system for oncology patients
New workflow integrates the xCELLigence RTCA HT with the BioTek BioSpa 8 Automated Incubator
The new company will utilize Teijin's drug discovery research technologies, facilities, equipment and personnel.
According to GlobalData’s analyst consensus forecast, OTX-2002 is projected to have the highest revenue by 2028, with sales of $1.6 billion during that year
The Innovation Explorer database of GlobalData’s Disruptor Intelligence Center highlights the key company collaborations in pharma to advance AI-powered drug repurposing techniques.
This clearance allows the company to initiate a clinical trial for patients with an ileal pouch-anal anastomosis
Subscribe To Our Newsletter & Stay Updated
